Loading…
Core Laboratories Inc. is projected to rise to $12.40 by 2027, a +12% move from its current price of $11.10. CLB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $10.82 | $11.09 | $11.38 | -0.05% |
| Jul 13 | $10.70 | $11.09 | $11.49 | -0.10% |
| Jul 14 | $10.61 | $11.08 | $11.58 | -0.15% |
| Jul 15 | $10.53 | $11.08 | $11.65 | -0.21% |
| Jul 16 | $10.46 | $11.07 | $11.71 | -0.26% |
| Jul 17 | $10.40 | $11.07 | $11.77 | -0.31% |
| Jul 18 | $10.35 | $11.06 | $11.82 | -0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.35 | $11.06 | $11.82 | -0.36% |
| Week 2 | $10.03 | $11.02 | $12.11 | -0.72% |
| Week 3 | $9.78 | $10.98 | $12.33 | -1.08% |
| Week 4 | $9.57 | $10.94 | $12.50 | -1.43% |
| Week 5 | $9.39 | $10.90 | $12.66 | -1.79% |
| Week 6 | $9.22 | $10.86 | $12.79 | -2.14% |
| Week 7 | $9.07 | $10.82 | $12.91 | -2.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments.
The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment.
It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc.
was founded in 1936 and is based in Houston, Texas.
Core Laboratories Inc. trades in the Energy sector and is currently priced at $11.43 per share. It has a market capitalization of $526.89M and ranks 2996 by market cap. The near-term outlook reflects a stable price path with a mix of potential gains over the forecast horizon.
The multi-year forecast shows a path from a flat start in 2026 to a substantially higher average by 2050, with a maximum projected price in the high past decade range and a strong long-run upside implied by the figures.
A major floor 21.6% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 25.6% above — a clean break opens room to run.
A major ceiling 58.6% above — clearing it would confirm fresh momentum.
Key CLB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.04 | Buy | $11.10 | Sell |
| MA 10 | $11.18 | Sell | $11.23 | Sell |
| MA 20 | $11.57 | Sell | $11.65 | Sell |
| MA 50 | $12.90 | Sell | $12.90 | Sell |
| MA 100 | $14.86 | Sell | $14.08 | Sell |
| MA 200 | $15.41 | Sell | $14.72 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.26 | Neutral |
| Stoch RSI (14) | 84.12 | Sell |
| CCI (20) | -56.12 | Neutral |
| Williams %R (14) | -63.81 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | -4.64 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 36.19 | Neutral |
| TRIX (15) | -0.77 | Sell |
| Awesome (5,34) | -1.42 | Sell |
| Ultimate (7,14,28) | 33.25 | Neutral |
| Momentum (10) | 0.18 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 10.95 | Buy |
| ADX (14) | 26.76 | Sell |
| ATR (14) | 0.28 | Info |
The 30-day technical picture is neutral. RSI14 is 30, indicating tentative upside momentum. The stock trades near the moving averages with SMA50 at $14.57 and SMA200 at $15.50, creating near-term resistance around $14.54 and support at $11.43. Over the last 30 days, the price range has been from $9.60 to $13.61, showing a broad but contained move.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.72 | $11.10 | $13.10 | 0% | Neutral | |
| $9.94 | $12.40 | $16.32 | +12% | Neutral | |
| $11.36 | $14.53 | $19.80 | +31% | Bullish | |
| $11.13 | $14.55 | $20.37 | +31% | Bullish | |
| $11.86 | $15.79 | $22.61 | +42% | Bullish | |
| $11.68 | $15.82 | $23.11 | +43% | Bullish | |
| $11.29 | $15.53 | $23.10 | +40% | Bullish | |
| $12.31 | $17.18 | $25.98 | +55% | Bullish | |
| $13.21 | $18.70 | $28.70 | +69% | Bullish | |
| $15.00 | $21.53 | $33.49 | +94% | Bullish | |
| $16.94 | $25.82 | $42.59 | +133% | Bullish | |
| $27.60 | $46.64 | $83.77 | +320% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.72 | $11.10 | $13.05 | +0.00% |
| August 2026 | $8.97 | $10.57 | $12.77 | -4.82% |
| September 2026 | $8.93 | $10.59 | $12.93 | +0.23% |
| October 2026 | $9.01 | $10.75 | $13.23 | +1.48% |
| November 2026 | $8.79 | $10.53 | $13.06 | -2.04% |
| December 2026 | $8.72 | $10.49 | $13.10 | -0.38% |
Click any year to see its month-by-month CLB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CLB price prediction for 2026 points to an average of $11.10 (low $10.72, high $13.10) — a potential gain of 0% on today's $11.10. Price action looks broadly range-bound.
In 2027, CLB is projected to trade between $9.94 and $16.32, averaging $12.40 — a potential gain of +12% from today's $11.10. That is up +12% on the projected 2026 average. A consolidation phase looks the most probable path here.
Core Laboratories Inc.'s 2028 outlook centres on $14.53, within a $11.36 to $19.80 range. That is up +17% on the projected 2027 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2029, CLB could reach as high as $20.37, with a base case around $14.55 and support toward $11.13 — roughly +31% from $11.10. Buyers look set to stay in control over this stretch.
Expect CLB to range from $11.86 to $22.61 through 2030. The $15.79 average target implies a +42% move from current prices. That is up +8% on the projected 2029 average. Momentum favours further upside here.
The CLB price prediction for 2031 points to an average of $15.82 (low $11.68, high $23.11) — a potential gain of +43% on today's $11.10. Buyers look set to stay in control over this stretch.
In 2032, CLB is projected to trade between $11.29 and $23.10, averaging $15.53 — a potential gain of +40% from today's $11.10. That is -2% versus the projected 2031 average. Momentum favours further upside here.
Core Laboratories Inc.'s 2033 outlook centres on $17.18, within a $12.31 to $25.98 range. That is up +11% on the projected 2032 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CLB could reach as high as $28.70, with a base case around $18.70 and support toward $13.21 — roughly +69% from $11.10. Momentum favours further upside here.
Expect CLB to range from $15.00 to $33.49 through 2035. The $21.53 average target implies a +94% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The CLB price prediction for 2040 points to an average of $25.82 (low $16.94, high $42.59) — a potential gain of +133% on today's $11.10. Momentum favours further upside here.
In 2050, CLB is projected to trade between $27.60 and $83.77, averaging $46.64 — a potential gain of +320% from today's $11.10. That is up +81% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLB today (≈ 90.09009 CLB) could be worth
$4,202.13
+$3,202.13 (+320%) by 2050 · US Dollar
Based on the average projected CLB price of $46.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLBwould be worth at today's price.
$1,000 invested in CLB on Jul 10, 2025 (≈ 77.279755 CLB) would be worth
$857.81
-$142.19 (-14.2%) today · 0.86× · US Dollar
Based on a CLB entry price of $12.94 vs. today's $11.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.46 | $968.59 | -3.1% |
| 1 month ago | $13.42 | $827.12 | -17.3% |
| 3 months ago | $16.51 | $672.32 | -32.8% |
| 6 months ago | $18.78 | $591.05 | -40.9% |
| 1 year ago | $12.94 | $857.81 | -14.2% |
| All time (5.0y) ago | $36.31 | $305.7 | -69.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLB forecast.
Our base-case forecast reaches $22.00 around 2040.
Implied market cap at $22.00: $1.01B
The multi-year forecast shows a bullish tilt beginning later in the horizon. In 2026 the min, avg, and max are $11.43, $11.43, and $14.02, with 0% ROI and NEUTRAL sentiment. By 2027 the avg is $12.91 with a max of $17.14 and ROI of 12.9%.
The 2028 forecast broadens to an avg of $14.89, max $20.47, ROI 30.3, with a BULLISH sentiment. The 2029 outlook has an avg of $15.27, max $21.60, ROI 33.6, BULLISH. The 2030 forecast shows an avg of $16.34, max $23.66, ROI 43, BULLISH.
Sentiment remains BULLISH through 2035, 2040, and beyond, with the 2035 avg $22.76 and max $35.90 (ROI 99.2), 2040 avg $26.14 and max $43.77 (ROI 128.7), and 2050 avg $49.63 with a max of $90.76 (ROI 334.2). Overall, the outlook suggests meaningful upside over the long term, but these figures are estimates and not guarantees. The forecast shows rising averages from the mid-teens into the high tens by 2050, with higher potential values in the max column.
Tap a question to reveal the answer.
According to the forecast, the 2030 average price is $16.34 with a max of $23.66 and ROI 43%.
The forecast shows a bullish trajectory in later years, with 2050 average $49.63 and ROI 334.2%, though early years include mixed sentiment and uncertainties.
The 2050 forecast shows an average price of $49.63 with a max of $90.76 and ROI 334.2%, indicating the potential to exceed $50 in some scenarios.
For 2026, the min is $11.43, the avg is $11.43, the max is $14.02, with ROI 0%.
The 2050 forecast shows an average price of $49.63, a min of $28.66, a max of $90.76, and ROI 334.2% with bullish sentiment.
Core Laboratories Inc. Community Discussion
0Share your Core Laboratories Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.